Background: Estimating cause-related mortality among the dead is not common, yet for clinical and public health purposes, a lot can be learnt from the dead. HIV/AIDS accounted for the third most frequent cause of deaths in Kenya; 39.7 deaths per 100,000 population in 2019. OraQuick® has previously been validated on oral fluid and implemented as a screening assay for HIV self-testing in Kenya among living subjects. We assessed the feasibility and diagnostic accuracy of OraQuick® for HIV screening among decedents. Methods: Trained morticians collected oral fluid from 132 pre- and post-embalmed decedents aged >18 months at Jaramogi Oginga Odinga Teaching and Referral Hospital mortuary in western Kenya and tested for HIV using OraQuick®. Test results were compared with those obtained using the national HIV Testing Services algorithm on matched pre-embalming whole blood specimens as a gold standard (Determine® HIV and First Response® HIV 1-2-O). We calculated positive predictive values (PPV), negative predictive values (NPV), Area Under Curve (AUC), sensitivity and specificity of OraQuick® compared to the national HTS algorithm. Results: OraQuick® had similar sensitivity of 92.6%, (95.0% confidence interval (CI):75.7- 99.1) on pre- and post-embalmed samples compared to the gold standard. Specificity was 97.1% (95.0% CI:91.9-99.4) and 95.2%, (95.0% CI:89.2-98.4) pre and post embalming respectively. Pre and post embalming PPV was 89.3% (95.0% CI:71.8-97.7) and 83.3% (95.0% CI:65.3-94.4) respectively. The AUC pre-and post embalming was 94.9% (95% CI: 89.6 - 100) and 93.9% (95% CI, 88.5 - 99.4) respectively. Conclusions: The study showed a relatively high performance sensitivity and specificity of OraQuick® HIV-1/2 test among decedents, similar to those observed among living subjects. OraQuick® HIV-1/2 presents a convenient and less invasive screening test for surveillance of HIV among decedents within a mortuary setting.
Background Breast self-examination (BSE) is a simple, low-cost, and non-invasive method that women use to detect breast cancer at early stages. BSE is recommended for teenage and adult women as it helps to detect unusual swelling and lumps. The early intervention reduces the spread of cancer cells and improves health outcomes. This study assessed the knowledge and practices of BSE for early detection of breast cancer among women attending maternal health clinic at Jaramogi Oginga Teaching and Referral Hospital (JOOTRH), Kisumu County in Kenya. Methods A cross-sectional study targeting women of reproductive age seeking maternal health services at the JOOTRH facility was conducted. Systematic sampling was used to select the study participants while purposive sampling was used to select the nurses involved in key informant interviews. Semi-structured questionnaires and recording were used to collect data. Descriptive and logistic regression was conducted for the quantitative data. Qualitative data was transcribed, coded and analyzed thematically. Results The study found that 39% of the participants had the correct knowledge and practice of BSE. An increase in education level was significantly associated with correct knowledge and practice of BSE. Single participants (aOR = 0.6, 95%CI [0.36–0.99]), participants who heard about BSE from media (aOR = 0.51, 95%CI [0.27–0.97]) and friends (aOR = 0.25, 95%CI [0.09–0.69]) were less likely to report correct knowledge and practice of BSE. Conclusion There needs to be concerted effort to raise the knowledge and practice of BSE by the national and county governments, stakeholders and health practitioners for the early detection of breast cancer.